Lowenstein PR - Search Results

1

Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.

Koschmann C, Zamler D, MacKay A, Robinson D, Wu YM, Doherty R, Marini B, Tran D, Garton H, Muraszko K, Robertson P, Leonard M, Zhao L, Bixby D, Peterson L, Camelo-Piragua S, Jones C, Mody R, Lowenstein PR, Castro MG. Koschmann C, et al. Among authors: lowenstein pr. Oncotarget. 2016 Oct 4;7(40):65696-65706. doi: 10.18632/oncotarget.11602. Oncotarget. 2016. PMID: 27582545 Free PMC article.

2

Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors.

Shering AF, Bain D, Stewart K, Epstein AL, Castro MG, Wilkinson GW, Lowenstein PR. Shering AF, et al. Among authors: lowenstein pr. J Gen Virol. 1997 Feb;78 ( Pt 2):445-59. doi: 10.1099/0022-1317-78-2-445. J Gen Virol. 1997. PMID: 9018068

3

Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro.

Stewart K, Brown OA, Morelli AE, Fairbairn LJ, Lashford LS, Cooper A, Hatton CE, Dexter TM, Castro MG, Lowenstein PR. Stewart K, et al. Among authors: lowenstein pr. Gene Ther. 1997 Jan;4(1):63-75. doi: 10.1038/sj.gt.3300364. Gene Ther. 1997. PMID: 9068797

4

FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors.

Larregina AT, Morelli AE, Dewey RA, Castro MG, Fontana A, Lowenstein PR. Larregina AT, et al. Among authors: lowenstein pr. Gene Ther. 1998 Apr;5(4):563-8. doi: 10.1038/sj.gt.3300615. Gene Ther. 1998. PMID: 9614583

5

Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cells.

Goya RG, Rowe J, Sosa YE, Tomasec P, Lowenstein PR, Castro MG. Goya RG, et al. Among authors: lowenstein pr. Mol Cell Endocrinol. 1998 Apr 30;139(1-2):199-207. doi: 10.1016/s0303-7207(98)00059-8. Mol Cell Endocrinol. 1998. PMID: 9705088

6

Politically correct gene therapy? A "clean environment" improves gene delivery to the brain!

Lowenstein PR, Thomas CE, Castro MG. Lowenstein PR, et al. Gene Ther. 1999 Apr;6(4):463-4. doi: 10.1038/sj.gt.3300917. Gene Ther. 1999. PMID: 10476205 No abstract available.

7

Generation of a recombinant herpes simplex virus type 1 expressing the rat corticotropin- releasing hormone precursor: endoproteolytic processing, intracellular targeting and biological activity.

Tomasec P, Preston CM, Linton EA, Ahmed I, Lowenstein PR, Castro MG. Tomasec P, et al. Among authors: lowenstein pr. Neuroendocrinology. 1999 Dec;70(6):439-50. doi: 10.1159/000054506. Neuroendocrinology. 1999. PMID: 10657737

8

Gene therapy for pituitary tumours.

Davis JR, Lowenstein PR, McNeilly AS, Castro MG. Davis JR, et al. Among authors: lowenstein pr. Endocr Relat Cancer. 1999 Dec;6(4):475-81. doi: 10.1677/erc.0.0060475. Endocr Relat Cancer. 1999. PMID: 10730901 Review. No abstract available.

9

Cell-type specific expression in the pituitary: physiology and gene therapy.

Castro MG, Windeatt S, Smith-Arica J, Lowenstein PR. Castro MG, et al. Among authors: lowenstein pr. Biochem Soc Trans. 1999 Dec;27(6):858-63. doi: 10.1042/bst0270858. Biochem Soc Trans. 1999. PMID: 10830117 Review. No abstract available.

10

The basic science of brain-tumour gene therapy.

Lowenstein PR, Cowen R, Thomas C, Castro MG. Lowenstein PR, et al. Biochem Soc Trans. 1999 Dec;27(6):873-81. doi: 10.1042/bst0270873. Biochem Soc Trans. 1999. PMID: 10830120 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page